T cell stimulation with peptides
Our peptides are efficient tools for in vitro
stimulation of antigen-specific CD8 T cells. Peptides are offered as single
peptides.
Please select
from a large range of peptides below in the “Category” option.
Save money with PepSets!
Upon ordering of 5 or 10 different peptides of choice, you will receive a discount of 17% or 25%, respectively. Please download your order form here and fax it back to us: Customers from the US and Canada, customers from Europe and other countries.
- Please inquite delivery time
- Can be shipped imnedialely
| Product | Contents | Cat.no | Price | Order | ||
|---|---|---|---|---|---|---|
| 1 mg | 6-7001-901 | USD 78.00 | ||||
|
CMV pp65 peptide NLVPMVATV (HLA-A0201) for stimulation of T-cells. Single peptide (NLVPMVATV) for stimulation of human CMV-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7002-901 | USD 78.00 | ||||
|
EBV peptide GLCTLVAML (HLA-A*0201) for stimulation of T-cells. Single peptide (GLCTLVAML) for stimulation of human EBV BMLF-1(280-288) CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7003-901 | USD 78.00 | ||||
|
Influenza M peptide GILGFVFTL (HLA-A*0201) for stimulation of T-cells. Single peptide (GILGFVFTL) for stimulation of human Influenza M1-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7004-901 | USD 78.00 | ||||
|
HIV gag peptide SLYNTVATL (HLA-A*0201) for stimulation of T-cells. Single peptide (SLYNTVATL) for stimulation of human HIV gag-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7005-901 | USD 78.00 | ||||
|
HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of T-cells. Single peptide ( ILKEPVHGV) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7006-901 | USD 78.00 | ||||
|
HBV core peptide FLPSDFFPSV (HLA-A*0201) for stimulation of T-cells. Single peptide (FLPSDFFPSV) for stimulation of human HBV core-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7007-901 | USD 78.00 | ||||
|
MART 1 peptide ELAGIGILTV (HLA-A*0201) for stimulation of T-cells. Single peptide (ELAGIGILTV) for stimulation of human MART 1-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7008-901 | USD 78.00 | ||||
|
Her-2/neu peptide KIFGSLAFL (HLA-A*0201) for stimulation of T-cells. Single peptide (KIFGSLAFL) for stimulation of human Her-2/neu-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7009-901 | USD 78.00 | ||||
|
Her-2/neu peptide RLLQETELV (HLA-A*0201) for stimulation of T-cells. Single peptide (RLLQETELV) for stimulation of human Her-2/neu-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||
| 1 mg | 6-7010-901 | USD 78.00 | ||||
|
Gp 100 peptide IMDQVPFSV (HLA-A*0201) for stimulation of T-cells. Single peptide (IMDQVPFSV) for stimulation of human Gp 100-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
||||||